Table 2. MINORS* literature quality evaluation form.
Study | Purpose of study | Coherence of patients included | Collection of expected date | Endpoint indicators appropriately reflect the purpose of study | Objective of endpoint indicators | Adequacy of follow-up time | Loss to follow-up rate less than 5% | Sample size evaluation | Inclusion criteria of control group | Parallel experiments at the same time | Baseline comparability between groups | Whether the statistical analysis is appropriate | MINORS score |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Yamashita et al. | 1 | 0 | 2 | 1 | 0 | 2 | 2 | 0 | 0 | 2 | 1 | 2 | 13 |
Deng et al. | 1 | 1 | 2 | 1 | 2 | 2 | 2 | 0 | 0 | 1 | 2 | 2 | 16 |
Khullar et al. | 2 | 0 | 2 | 2 | 2 | 2 | 2 | 0 | 0 | 1 | 1 | 2 | 16 |
Kodama et al. | 1 | 1 | 2 | 1 | 1 | 2 | 2 | 0 | 2 | 1 | 2 | 2 | 17 |
Nishio et al. | 1 | 2 | 2 | 2 | 1 | 2 | 2 | 0 | 2 | 2 | 2 | 2 | 20 |
Koike et al. | 1 | 2 | 2 | 1 | 1 | 2 | 2 | 0 | 0 | 2 | 2 | 2 | 17 |
Chan et al. | 2 | 2 | 2 | 2 | 1 | 2 | 2 | 0 | 0 | 2 | 2 | 2 | 19 |
Shao et al. | 2 | 1 | 2 | 2 | 1 | 2 | 2 | 0 | 0 | 0 | 2 | 2 | 16 |
Saji et al. | 2 | 2 | 2 | 2 | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 23 |
Stamatis et al. | 2 | 2 | 2 | 2 | 1 | 2 | 2 | 0 | 2 | 2 | 2 | 2 | 21 |
*, literature with a score of 0–8 was of low quality, 9–16 was of moderate quality, and 17–24 was of high quality. Literature with a MINORS score of less than 12 should not be included in the meta-analysis. MINORS, Methodological Index for Nonrandomized Studies.